Welcome to the NRDL+ Newsletter Community!

Hi, I’m Kelly Ke, author of the NRDL+ newsletter. Thank you for inviting me into your inbox—and for your valuable time. I’m thrilled to have you here.

The NRDL+ newsletter was created to fill the gap in English-language insights on China’s fast-evolving market access environment for innovative medicines. It’s designed to keep you informed, provide context that matters, and help you develop a holistic, nuanced understanding of China’s healthcare and access landscape.

As a member of the NRDL+ community, here’s what you can expect:

• Timely policy alerts powered by Access360, our real-time policy intelligence platform
• Select bulletins and deep-dive analyses reserved exclusively for members
• Special offers and updates on our premier programs and Masterclasses

Congratulations—you’re officially part of the NRDL+ community!

Warm regards,
Kelly Ke
Creator, NRDL+ Executive Debrief